News
Finding May Help Predict Pancreatic NET Recurrence
NETRF-funded researchers identified a cancer cell type that is associated with non-functional pancreatic neuroendocrine tumor (pNET) recurrence. Alpha-like pNET cell expression of the protein ARX can guide prognosis.
Grant Applications Go to Board of Scientific Advisors
NETRF’s Board of Scientific Advisors and external reviewers will begin reading and ranking the 2019 requests for research funding. Wide Range of Requests for NET
In Memory of Carol Branaman
Neuroendocrine cancer community faces loss. Carol Branaman, vice chair and former chair of NETRF, passes from neuroendocrine cancer.
Rocks that Bring Hope
From a place of discouragement after being diagnosed with a NET in June 2018, Susan Garrett of Roxboro, NC, saw a news story on WRAL
NETRF 2019 Research Symposium
Latest in NET Cancer Research Neuroendocrine Tumor Research Foundation (NETRF) held its 11th Annual Research Symposium on May 2-3, 2019, in Cambridge, MA. More than
Developing a NET Cell Line
NETRF & Broad Institute Work to Fill Research Void The lack of publicly available, reliable NET cell lines is a barrier in neuroendocrine tumor research,
Exploring Targeted Alpha Therapy for Neuroendocrine Tumors
Increasing Precision in Cancer Cell Death to Prevent Metastasis In housework and lawn work, it is important to have the right tool for the job.
Gold Seal GuideStar
NETRF given the highest ranking for financial responsibility and transparency by leading nonprofit rating program, GoldStar.
Celebrating NET Specialists on Doctors Day 2019
NETRF is so pleased to report that we received several gifts honoring many NET doctors around the country on March 30th, National Doctor’s Day! Thank
New Mentored Award to Help Launch NET Careers
The Neuroendocrine Tumor Research Foundation (NETRF) announces a new NETRF Mentored Award for early career researchers, supported by Ipsen. The two-year grant for those in